myelin-oligodendrocyte-glycoprotein-(35-55) has been researched along with propyphenazone* in 1 studies
1 other study(ies) available for myelin-oligodendrocyte-glycoprotein-(35-55) and propyphenazone
Article | Year |
---|---|
Nociception in a Progressive Multiple Sclerosis Model in Mice Is Dependent on Spinal TRPA1 Channel Activation.
Central neuropathic pain is a common untreated symptom in progressive multiple sclerosis (PMS) and is associated with poor quality of life and interference with patients' daily activities. The neuroinflammation process and mitochondrial dysfunction in the PMS lesions generate reactive species. The transient potential receptor ankyrin 1 (TRPA1) has been identified as one of the major mechanisms that contribute to neuropathic pain signaling and can be activated by reactive compounds. Thus, the goal of our study was to evaluate the role of spinal TRPA1 in the central neuropathic pain observed in a PMS model in mice. We used C57BL/6 female mice (20-30 g), and the PMS model was induced by the experimental autoimmune encephalomyelitis (EAE) using mouse myelin oligodendrocyte glycoprotein (MOG Topics: Acetanilides; Acetophenones; Analgesics; Animals; Antipyrine; Dipyrone; Encephalomyelitis, Autoimmune, Experimental; Female; Hyperalgesia; Mice; Mice, Inbred C57BL; Myelin-Oligodendrocyte Glycoprotein; NADPH Oxidases; Nerve Tissue Proteins; Neuralgia; Nociception; Oligonucleotides, Antisense; Oxidative Stress; Oximes; Peptide Fragments; Pregabalin; Purines; Spinal Cord; Thioctic Acid; TRPA1 Cation Channel; Up-Regulation | 2020 |